Skip to main content
. 2018 Dec 13;175(7):1731–1743.e13. doi: 10.1016/j.cell.2018.10.014

Table 1.

Characteristics of Patients with Recurrent or Metastatic SCCHN, Enrolled in the NCT02643550 Phase II Clinical Trial

Patient Characteristics, N = 31
N (%)
Age, median [range] 64 [34–76]
Sex female 10 (32)
male 21 (68)
ECOG 0 12 (39)
1 19 (61)
HPV status positive 4 (13)
negative 15 (48)
to be determined 12 (39)
Tobacco never 6 (19)
former 20 (65)
current 5 (16)
Tumor site oral cavity 14 (45)
oropharynx 10 (32)
larynx 4 (13)
hypopharynx 2 (6)
nasopharynx 1 (3)
Type of recurrence local 18 (58)
distant 13 (42)
Prior lines of systemic therapy (overall) Number of Previous Lines
1 16 (52)
2 10 (32)
3 5 (16)
prior platinum 31 (100)
prior IO 14 (45)
prior cetuximab 3 (10)